Inventor
PIKE KURT GORDON
GB19 patents
⚠️ This page may combine multiple inventors who share the name “PIKE KURT GORDON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
18 patentsUS7842694B2Nov 30, 2010
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ASTRAZENECA AB11 citations92
US7642263B2Jan 5, 2010
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ASTRAZENECA AB16 citations92
US7642259B2Jan 5, 2010
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ASTRAZENECA AB18 citations92
US7745475B2Jun 29, 2010
Heteroaryl benzamide derivatives as GLK activators
ASTRAZENECA AB14 citations83
US7671060B2Mar 2, 2010
Heteroaryl benzamide derivatives
ASTRAZENECA AB13 citations81
US9856255B2Jan 2, 2018
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB3 citations72
US10457679B2Oct 29, 2019
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB3 citations71
US11613539B2Mar 28, 2023
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations61
US10882858B2Jan 5, 2021
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations61
US12410187B2Sep 9, 2025
Fused tricyclic compounds useful as anticancer agents
ASTRAZENECA AB0 citations57
US7902200B2Mar 8, 2011
Chemical compounds
ASTRAZENECA AB4 citations56
US10189834B2Jan 29, 2019
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations51
US9822111B2Nov 21, 2017
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations51
US9428503B2Aug 30, 2016
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer
ASTRAZENECA AB0 citations51
US7977328B2Jul 12, 2011
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ASTRAZENECA AB0 citations51
US7750003B2Jul 6, 2010
Compounds-943
ASTRAZENECA AB2 citations51
US7964725B2Jun 21, 2011
Heteroarylbenzamide derivatives for use in the treatment of diabetes
ASTRAZENECA AB0 citations49
US7943607B2May 17, 2011
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ASTRAZENECA AB0 citations41